These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 17661719)
1. Ron-receptor tyrosine kinase in tumorigenesis and metastasis. Leonis MA; Thobe MN; Waltz SE Future Oncol; 2007 Aug; 3(4):441-8. PubMed ID: 17661719 [TBL] [Abstract][Full Text] [Related]
2. RON, a tyrosine kinase receptor involved in tumor progression and metastasis. Camp ER; Liu W; Fan F; Yang A; Somcio R; Ellis LM Ann Surg Oncol; 2005 Apr; 12(4):273-81. PubMed ID: 15827676 [TBL] [Abstract][Full Text] [Related]
3. HGFL supports mammary tumorigenesis by enhancing tumor cell intrinsic survival and influencing macrophage and T-cell responses. Benight NM; Wagh PK; Zinser GM; Peace BE; Stuart WD; Vasiliauskas J; Pathrose P; Starnes SL; Waltz SE Oncotarget; 2015 Jul; 6(19):17445-61. PubMed ID: 25938541 [TBL] [Abstract][Full Text] [Related]
4. Oncogenic and invasive potentials of human macrophage-stimulating protein receptor, the RON receptor tyrosine kinase. Wang MH; Wang D; Chen YQ Carcinogenesis; 2003 Aug; 24(8):1291-300. PubMed ID: 12807733 [TBL] [Abstract][Full Text] [Related]
5. Oncogenic signaling pathways activated by RON receptor tyrosine kinase. Danilkovitch-Miagkova A Curr Cancer Drug Targets; 2003 Feb; 3(1):31-40. PubMed ID: 12570659 [TBL] [Abstract][Full Text] [Related]
6. Oncogenesis of RON receptor tyrosine kinase: a molecular target for malignant epithelial cancers. Wang MH; Yao HP; Zhou YQ Acta Pharmacol Sin; 2006 Jun; 27(6):641-50. PubMed ID: 16723080 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic implications of a human neutralizing antibody to the macrophage-stimulating protein receptor tyrosine kinase (RON), a c-MET family member. O'Toole JM; Rabenau KE; Burns K; Lu D; Mangalampalli V; Balderes P; Covino N; Bassi R; Prewett M; Gottfredsen KJ; Thobe MN; Cheng Y; Li Y; Hicklin DJ; Zhu Z; Waltz SE; Hayman MJ; Ludwig DL; Pereira DS Cancer Res; 2006 Sep; 66(18):9162-70. PubMed ID: 16982759 [TBL] [Abstract][Full Text] [Related]
8. Met-related receptor tyrosine kinase Ron in tumor growth and metastasis. Wagh PK; Peace BE; Waltz SE Adv Cancer Res; 2008; 100():1-33. PubMed ID: 18620091 [TBL] [Abstract][Full Text] [Related]
9. Point mutations and overexpression of Ron induce transformation, tumor formation, and metastasis. Peace BE; Hughes MJ; Degen SJ; Waltz SE Oncogene; 2001 Sep; 20(43):6142-51. PubMed ID: 11593422 [TBL] [Abstract][Full Text] [Related]
10. Point mutations in the tyrosine kinase domain release the oncogenic and metastatic potential of the Ron receptor. Santoro MM; Penengo L; Minetto M; Orecchia S; Cilli M; Gaudino G Oncogene; 1998 Aug; 17(6):741-9. PubMed ID: 9715276 [TBL] [Abstract][Full Text] [Related]
11. Vitamin D3-dependent VDR signaling delays ron-mediated breast tumorigenesis through suppression of β-catenin activity. Johnson AL; Zinser GM; Waltz SE Oncotarget; 2015 Jun; 6(18):16304-20. PubMed ID: 26008979 [TBL] [Abstract][Full Text] [Related]
12. Mammary-specific Ron receptor overexpression induces highly metastatic mammary tumors associated with beta-catenin activation. Zinser GM; Leonis MA; Toney K; Pathrose P; Thobe M; Kader SA; Peace BE; Beauman SR; Collins MH; Waltz SE Cancer Res; 2006 Dec; 66(24):11967-74. PubMed ID: 17178895 [TBL] [Abstract][Full Text] [Related]
13. Ron receptor signaling augments mammary tumor formation and metastasis in a murine model of breast cancer. Peace BE; Toney-Earley K; Collins MH; Waltz SE Cancer Res; 2005 Feb; 65(4):1285-93. PubMed ID: 15735014 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of co-expression of RON and MET receptors in node-negative breast cancer patients. Lee WY; Chen HH; Chow NH; Su WC; Lin PW; Guo HR Clin Cancer Res; 2005 Mar; 11(6):2222-8. PubMed ID: 15788670 [TBL] [Abstract][Full Text] [Related]
15. The DEK oncogene promotes cellular proliferation through paracrine Wnt signaling in Ron receptor-positive breast cancers. Privette Vinnedge LM; Benight NM; Wagh PK; Pease NA; Nashu MA; Serrano-Lopez J; Adams AK; Cancelas JA; Waltz SE; Wells SI Oncogene; 2015 Apr; 34(18):2325-36. PubMed ID: 24954505 [TBL] [Abstract][Full Text] [Related]
16. Conditional deletion of β-catenin in mammary epithelial cells of Ron receptor, Mst1r, overexpressing mice alters mammary tumorigenesis. Wagh PK; Zinser GM; Gray JK; Shrestha A; Waltz SE Endocrinology; 2012 Jun; 153(6):2735-46. PubMed ID: 22474186 [TBL] [Abstract][Full Text] [Related]
17. The MSP-RON axis stimulates cancer cell growth in models of triple negative breast cancer. Millar R; Kilbey A; Remak SJ; Severson TM; Dhayade S; Sandilands E; Foster K; Bryant DM; Blyth K; Coffelt SB Mol Oncol; 2020 Aug; 14(8):1868-1880. PubMed ID: 32484599 [TBL] [Abstract][Full Text] [Related]
18. The RON receptor tyrosine kinase promotes metastasis by triggering MBD4-dependent DNA methylation reprogramming. Cunha S; Lin YC; Goossen EA; DeVette CI; Albertella MR; Thomson S; Mulvihill MJ; Welm AL Cell Rep; 2014 Jan; 6(1):141-54. PubMed ID: 24388747 [TBL] [Abstract][Full Text] [Related]
19. Altered expression of the RON receptor tyrosine kinase in various epithelial cancers and its contribution to tumourigenic phenotypes in thyroid cancer cells. Wang MH; Lee W; Luo YL; Weis MT; Yao HP J Pathol; 2007 Dec; 213(4):402-11. PubMed ID: 17955509 [TBL] [Abstract][Full Text] [Related]
20. β-Catenin is required for Ron receptor-induced mammary tumorigenesis. Wagh PK; Gray JK; Zinser GM; Vasiliauskas J; James L; Monga SP; Waltz SE Oncogene; 2011 Aug; 30(34):3694-704. PubMed ID: 21423209 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]